CLINICAL_TRIALS
trial_result
· 2023-07-07
Clinical Trial Update: Low-Dose Ketamine in Children With ADNP Syndrome [Phase 1, Phase 2]
Summary
A clinical trial exploring low-dose ketamine in children with ADNP syndrome has completed Phase 1 and Phase 2, with results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alexander Kolevzon | Conditions: ADNP Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-07-07